IE
PBAXU

Israel Englander’s Phoenix Biotech Acquisition Corp. Unit PBAXU Stock Holding History

Israel Englander’s Portfolio PBAXU Stock Details PBAXU Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		– Sell
-10,000
Closed -$101K – 7249
2022
Q3 		$101K Hold
10,000
– – ﹤0.01% 5966
2022
Q2 		$101K Hold
10,000
– – ﹤0.01% 5923
2022
Q1 		$101K Sell
10,000
-217,500
-96% -$2.2M ﹤0.01% 6143
2021
Q4 		$2.29M Buy
+227,500
New +$2.3M ﹤0.01% 3651

Other funds holding PBAXU

YCM
Yakira Capital Management Westport, Connecticut $351M AUM 21.82% 1-Year Est. Return
FTUS
Flow Traders U.S. New York $2.43B AUM 44.44% 1-Year Est. Return
TRCT
Tower Research Capital (TRC) New York $4.08B AUM 58.77% 1-Year Est. Return

Israel Englander's PBAXU Position: Q4 2022 in Review

Israel Englander sold out of Phoenix Biotech Acquisition Corp. Unit (PBAXU) in Q4 2022, closing a stake of 10,000 shares — an estimated $101K sold.

Israel Englander first reported a position in PBAXU in Q4 2021 and held it in 4 quarters. The position peaked at $2.29M in Q4 2021. 3 funds tracked by Wall St. Rank hold PBAXU as of Q4 2022.

  • Israel Englander reported no remaining Phoenix Biotech Acquisition Corp. Unit position as of Q4 2022 after selling out during the quarter.
  • Israel Englander sold 10,000 Phoenix Biotech Acquisition Corp. Unit shares in Q4 2022, an estimated $101K.
  • Israel Englander first reported a position in Phoenix Biotech Acquisition Corp. Unit in Q4 2021 and held it in 4 quarters.
  • Israel Englander's Phoenix Biotech Acquisition Corp. Unit position peaked at $2.29M in Q4 2021.
  • 3 funds tracked by Wall St. Rank held Phoenix Biotech Acquisition Corp. Unit as of Q4 2022.

Based on Millennium Management's 13F filing for Q4 2022, filed 14 Feb 2023.